availability of semaglutide GLP-1s Semaglutide (Ozempic) Market: Navigating The

Inclusion criteria of TRAILBLAZER-ALZ 2 are similar to those of TRAILBLAZER-ALZ: a 6-month history of worsening memory and positive amyloid (flortaucipir) PET

While Ozempic is a GLP-1 agonist, Mounjaro is classified as a glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist, or dual GIP/GLP-1 agonist, meaning it targets an additional pathway to help control blood sugar (and as a side effect, help with weight loss)

Clinical studies have shown that semaglutide injections, such as Ozempic, can contribute to significant weight loss when combined with a reduced-calorie diet and additional physical activity

20%, p = 0.049)

Depending on your prescription, your provider may create a personalized dosing schedule based on your health history to help you achieve your goals while minimizing your risk of side effects